NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 2 hours 21 min ago

Understanding the Basic Mechanisms of Immune-related Adverse Events (irAEs) in Cancer Immunotherapy

Tue, 2022-05-03 10:36
Notice NOT-CA-22-063 from the NIH Guide for Grants and Contracts

Notice of Special Interest (NOSI): Towards Developing a Cure for HBV in HIV/HBV Co-Infection

Fri, 2022-04-29 12:51
Notice NOT-AI-22-043 from the NIH Guide for Grants and Contracts

NIH Response to Registration Issues in SAM.gov

Fri, 2022-04-29 10:30
Notice NOT-OD-22-119 from the NIH Guide for Grants and Contracts

Notice of Special Interest: Research on Alcohol and Coronavirus Disease (COVID-19) within the Mission of NIAAA

Fri, 2022-04-29 03:04
Notice NOT-AA-22-012 from the NIH Guide for Grants and Contracts

Education Program on Translational Devices (R25 Clinical Trial Not Allowed)

Thu, 2022-04-28 11:14
Funding Opportunity PAR-22-146 from the NIH Guide for Grants and Contracts. This FOA solicits Research Education Grant (R25) applications to develop and implement a short course focused on (1) steps required for successful medical device development, translation, and commercialization (2) common technical and strategic challenges, and (3) best-practices and resources for each stage in the process. Applicants may choose to include an extended mentorship plan if they see fit. The short course should address a broad audience, including senior post-doctoral fellows, independent academic researchers, clinician scientists, and small business entrepreneurs interested in developing, translating, and/or commercializing medical devices to diagnose or treat a nervous system disorder.

NIAMS Rheumatic Diseases Research Resource-based Centers (P30 - Clinical Trial Not Allowed)

Wed, 2022-04-27 11:37
Funding Opportunity RFA-AR-23-002 from the NIH Guide for Grants and Contracts. NIAMS Rheumatic Diseases Research Resource-based Centers (P30 - Clinical Trial Not Allowed)

Notice of Special Interest (NOSI): Administrative Supplements for Lyme Disease and other Tickborne Illnesses

Wed, 2022-04-27 11:30
Notice NOT-AI-22-048 from the NIH Guide for Grants and Contracts

NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)

Wed, 2022-04-27 10:58
Funding Opportunity RFA-RM-22-021 from the NIH Guide for Grants and Contracts. The NIH Director's Early Independence Award supports exceptional junior investigators who wish to pursue independent research soon after completion of their terminal doctoral degree or post-graduate clinical training, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the research workforce. Individuals from diverse backgrounds, including those from underrepresented groups and from the full spectrum of eligible institutions in all geographic locations, are strongly encouraged to apply to this Funding Opportunity Announcement. In addition, applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. The NIH Director's Early Independence Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund.

Pages